A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

Merus has reported a 79% 12-month survival rate in cancer patients on its bispecific antibody, cementing William Blair ...

The House bill includes SALT cap increases, changes to Medicaid and SNAP and new rules to claim child tax credits.

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

UnitedHealth Group Incorporated (NYSE:UNH)’s UnitedHealthcare, the largest private health insurer in the U.S., is facing unprecedented public and regulatory scrutiny amid mounting patient frustration ...

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform ...

A new government-issued report reflects some of the most controversial views on vaccines, the nation’s food supply, ...

The protections in place, known as the Flores Settlement, largely limit to 72 hours the amount of time that child migrants ...

But because of that, my sun exposure throughout my life has been horrible. I started with tanning beds when I was a child ...